Impetigo: A need for new therapies in a world of increasing antimicrobial resistance.

Abstract

WHAT IS KNOWN AND OBJECTIVE:

Impetigo is a highly contagious bacterial skin infection and is one of the most common skin infections in children. Antibiotics are the first-line treatment when multiple lesions exist, but with an increasing prevalence of antibiotic-resistant bacteria the successful management of impetigo in the future is an area of concern.

COMMENT:

Current treatment options that favour the use of oral antibiotic therapy are increasingly problematic. Widespread use of these agents contributes to antimicrobial resistance and has adverse consequences for individuals and communities. There is a need for new topical antimicrobials and antiseptics as an alternative treatment strategy.

WHAT IS NEW AND CONCLUSION:

To successfully treat impetigo into the future and ensure that therapy does not contribute to bacterial resistance, additional research is required to ascertain the usefulness of alternative agents, including new topical antimicrobials and antiseptics.

• Authors: N M D'Cunha, G M Peterson, K E Baby, J Thomas
• Journal: Journal of clinical pharmacy and therapeutics (J Clin Pharm Ther) Vol. 43 Issue 1 Pg. 150-153 (Feb 2018) ISSN: 1365-2710 [Electronic] England
• PMID: 29063621 (Publication Type: Journal Article)
• Copyright: © 2017 John Wiley & Sons Ltd.

Chemical References

• Anti-Bacterial Agents

Topics

• Anti-Bacterial Agents (therapeutic use)
• Bacteria (drug effects)
• Bacterial Infections (drug therapy)
• Drug Resistance, Bacterial (drug effects)
• Humans
• Impetigo (drug therapy)